{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:48:01Z","timestamp":1790610481405,"version":"4.1.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["3-SRA-2017-345-S-B, 1-SRA-2020-977-S-B , 1-INO-2022-1116-A-N"],"award-info":[{"award-number":["3-SRA-2017-345-S-B, 1-SRA-2020-977-S-B , 1-INO-2022-1116-A-N"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK127637"],"award-info":[{"award-number":["DK127637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Posttranslational protein modifications (PTMs) are an inherent response to physiological changes causing altered protein structure and potentially modulating important biological functions of the modified protein. Besides cellular metabolic pathways that may be dictated by PTMs, the subtle change of proteins also may provoke immune attack in numerous autoimmune diseases. Type 1 diabetes (T1D) is a chronic autoimmune disease destroying insulin-producing beta cells within the pancreatic islets, a result of tissue inflammation to specific autoantigens. This review summarizes how PTMs arise and the potential pathological consequence of PTMs, with particular focus on specific autoimmunity to pancreatic beta cells and cellular metabolic dysfunction in T1D. Moreover, we review PTM-associated biomarkers in the prediction, diagnosis and in monitoring disease activity in T1D. Finally, we will discuss potential preventive and therapeutic approaches of targeting PTMs in repairing or restoring normal metabolic pathways in pancreatic islets.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1028130","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T05:58:55Z","timestamp":1666850335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes"],"prefix":"10.3389","volume":"13","author":[{"given":"Mei-Ling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Kibbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Mamula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.337487","article-title":"Posttranslational covalent modification of proteins","volume":"198","author":"Uy","year":"1977","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.12.003","article-title":"Autoantigenesis: The evolution of protein modifications in autoimmune disease","volume":"24","author":"Doyle","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2013.850495","article-title":"Autoantigens: Novel forms and presentation to the immune system","volume":"47","author":"Doyle","year":"2014","journal-title":"Autoimmunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the beta-cell (Do not blame the immune system)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756548","article-title":"Tse HM. partners in crime: Beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis","volume":"12","author":"Toren","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3247-4","article-title":"Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using lc-Maldi-Tof\/Tof","volume":"35","author":"Wang","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated Protein\/Peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-ccp antibodies: The past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678953","article-title":"Citrullination and pad enzyme biology in type 1 diabetes - regulators of inflammation, autoimmunity, and pathology","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/s41467-022-29512-0","article-title":"Citrullination of glucokinase is linked to autoimmune diabetes","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7382","article-title":"Oxidative modifications in tissue pathology and autoimmune disease","volume":"29","author":"Yang","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.06.003","article-title":"Metabolic cycles and signals for insulin secretion","volume":"34","author":"Merrins","year":"2022","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cmet.2020.10.007","article-title":"Pyruvate kinase controls signal strength in the insulin secretory pathway","volume":"32","author":"Lewandowski","year":"2020","journal-title":"Cell Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.02.008","article-title":"Mitochondrial gtp regulates glucose-stimulated insulin secretion","volume":"5","author":"Kibbey","year":"2007","journal-title":"Cell Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.011775","article-title":"Phosphoenolpyruvate cycling Via mitochondrial phosphoenolpyruvate carboxykinase links anaplerosis and mitochondrial gtp with insulin secretion","volume":"284","author":"Stark","year":"2009","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.713362","article-title":"Characterization of diabetogenic Cd8+ T cells: Immune therapy with metabolic blockade","volume":"291","author":"Garyu","year":"2016","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12933-021-01213-w","article-title":"Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700517200","article-title":"Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation","volume":"282","author":"Bjorkhaug","year":"2007","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.393769","article-title":"Sumoylation of pancreatic glucokinase regulates its cellular stability and activity","volume":"288","author":"Aukrust","year":"2013","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669456","article-title":"Glycolysis inhibition induces functional and metabolic exhaustion of Cd4(+) T cells in type 1 diabetes","volume":"12","author":"Martins","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05030-5","article-title":"Activation of the Hif1alpha\/Pfkfb3 stress response pathway in beta cells in type 1 diabetes","volume":"63","author":"Nomoto","year":"2020","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-010-1047-4","article-title":"Immunoreactivity of neuron-specific enolase (Nse) in human pancreas in health and type 1 diabetes mellitus","volume":"149","author":"Proshchina","year":"2010","journal-title":"Bull Exp Biol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2585","article-title":"Characterization of glycolytic enzymes and pyruvate kinase M2 in type 1 and 2 diabetic nephropathy","volume":"42","author":"Gordin","year":"2019","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-021-00813-0","article-title":"Posttranslational modification of pyruvate kinase type M2 (Pkm2): Novel regulation of its biological roles to be further discovered","volume":"77","author":"Zheng","year":"2021","journal-title":"J Physiol Biochem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.05.065","article-title":"Sirt5 desuccinylates and activates pyruvate kinase M2 to block macrophage il-1beta production and to prevent dss-induced colitis in mice","volume":"19","author":"Wang","year":"2017","journal-title":"Cell Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.849625","article-title":"Regulation of glucose, fatty acid and amino acid metabolism by ubiquitination and sumoylation for cancer progression","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4328","article-title":"Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction","volume":"23","author":"Qi","year":"2017","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cmet.2018.01.016","article-title":"The mitochondrial acylome emerges: Proteomics, regulation by sirtuins, and metabolic and disease implications","volume":"27","author":"Carrico","year":"2018","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-019-02780-x","article-title":"Succinylation links metabolism to protein functions","volume":"44","author":"Yang","year":"2019","journal-title":"Neurochem Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00339.2010","article-title":"Ss-Cell-Specific pyruvate dehydrogenase deficiency impairs glucose-stimulated insulin secretion","volume":"299","author":"Srinivasan","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1130-9","article-title":"The role of pyruvate carboxylase in insulin secretion and proliferation in rat pancreatic beta cells","volume":"51","author":"Xu","year":"2008","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0199-4","article-title":"Glucose-dependent partitioning of arginine to the urea cycle protects beta-cells from inflammation","volume":"2","author":"Fu","year":"2020","journal-title":"Nat Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110037","article-title":"Glucose metabolism and pyruvate carboxylase enhance glutathione synthesis and restrict oxidative stress in pancreatic islets","volume":"37","author":"Fu","year":"2021","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107832200","article-title":"Catalytic activity and chaperone function of human protein-disulfide isomerase are required for the efficient refolding of proinsulin","volume":"277","author":"Winter","year":"2002","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0989","article-title":"Carbonyl post-translational modification associated with early-onset type 1 diabetes autoimmunity","volume":"71","author":"Yang","year":"2022","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.22.473924","article-title":"A discovery-based proteomics approach identifies protein disulfide isomerase (Pdia1) as a biomarker of B cell stress in type 1 diabetes","author":"Syed","year":"2021","journal-title":"bioRxiv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0295","article-title":"Inflammation-induced citrullinated glucose-regulated protein 78 elicits immune responses in human type 1 diabetes","volume":"67","author":"Buitinga","year":"2018","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0621","article-title":"Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes","volume":"64","author":"Rondas","year":"2015","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051251","article-title":"The insulin a-chain epitope recognized by human T cells is posttranslationally modified","volume":"202","author":"Mannering","year":"2005","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12775","article-title":"Human islets and dendritic cells generate post-translationally modified islet autoantigens","volume":"185","author":"McLaughlin","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1214","article-title":"Posttranslational modification of hla-dq binding islet autoantigens in type 1 diabetes","volume":"63","author":"van Lummel","year":"2014","journal-title":"Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3746-x","article-title":"Antibodies to post-translationally modified insulin in type 1 diabetes","volume":"58","author":"Strollo","year":"2015","journal-title":"Diabetologia"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3132","article-title":"Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies","volume":"35","author":"Strollo","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4296-1","article-title":"Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children","volume":"60","author":"Strollo","year":"2017","journal-title":"Diabetologia"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-018-0250-3","article-title":"Low hla binding of diabetes-associated Cd8+ T-cell epitopes is increased by post translational modifications","volume":"19","author":"Sidney","year":"2018","journal-title":"BMC Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(94)93061-9","article-title":"Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus","volume":"343","author":"Lohmann","year":"1994","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.8.1987","article-title":"Gad65-specific Cd4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes","volume":"53","author":"Reijonen","year":"2004","journal-title":"Diabetes"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12034","article-title":"Cd4+ T cells recognize diverse epitopes within Gad65: Implications for repertoire development and diabetes monitoring","volume":"138","author":"Yang","year":"2013","journal-title":"Immunology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1952","article-title":"Recognition of posttranslationally modified Gad65 epitopes in subjects with type 1 diabetes","volume":"63","author":"McGinty","year":"2014","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11892-015-0657-7","article-title":"T Cell epitopes and post-translationally modified epitopes in type 1 diabetes","volume":"15","author":"McGinty","year":"2015","journal-title":"Curr Diabetes Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nm0217-264a","article-title":"Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"23","author":"Babon","year":"2017","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0288","article-title":"Islet amyloid polypeptide is a target antigen for diabetogenic Cd4+ T cells","volume":"60","author":"Delong","year":"2011","journal-title":"Diabetes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/db22-186-OR","article-title":"186-or: Novel autoantibodies to deamidated Ia2 extracellular domain in type 1 diabetes","volume":"71","author":"Jia","year":"2022","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2004.03.009","article-title":"Increased in vivo frequency of ia-2 peptide-reactive Ifngamma+\/Il-4- T cells in type 1 diabetic subjects","volume":"23","author":"Herzog","year":"2004","journal-title":"J Autoimmun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"C420","DOI":"10.1152\/ajpcell.00141.2019","article-title":"Oxidative stress pathways in pancreatic beta cells and insulin sensitive cells and tissues - importance to cell metabolism, function and dysfunction","volume":"317","author":"Newsholme","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101169","article-title":"A guide to understanding endoplasmic reticulum stress in metabolic disorders","volume":"47","author":"Lemmer","year":"2021","journal-title":"Mol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(91)91017-7","article-title":"Measuring the balance between insulin synthesis and insulin release","volume":"178","author":"Schuit","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13531","article-title":"Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes","volume":"1418","author":"Arunagiri","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00048","article-title":"Er stress proteins in autoimmune and inflammatory diseases","volume":"3","author":"Morito","year":"2012","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00067","article-title":"Beta cell er stress and the implications for immunogenicity in type 1 diabetes","volume":"3","author":"Marre","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00262","article-title":"Environmental factors contribute to beta cell endoplasmic reticulum stress and neo-antigen formation in type 1 diabetes","volume":"8","author":"Marre","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01766.x","article-title":"Increased stress protein Orp150 autoantibody production in type 1 diabetic patients","volume":"23","author":"Nakatani","year":"2006","journal-title":"Diabetes Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111783","article-title":"A novel pathogenic role of the er chaperone Grp78\/Bip in rheumatoid arthritis","volume":"209","author":"Yoo","year":"2012","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201707143","article-title":"Ire1-Xbp1 pathway regulates oxidative proinsulin folding in pancreatic beta cells","volume":"217","author":"Tsuchiya","year":"2018","journal-title":"J Cell Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002277","article-title":"The Ire1alpha\/Xbp1s pathway is essential for the glucose response and protection of beta cells","volume":"13","author":"Hassler","year":"2015","journal-title":"PloS Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107525","article-title":"Role of the Ero1-pdi interaction in oxidative protein folding and disease","volume":"210","author":"Shergalis","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.1.240","article-title":"Distinguishing covariation from causation in diabetes: A lesson from the protein disulfide isomerase mrna abundance trait","volume":"53","author":"Lan","year":"2004","journal-title":"Diabetes"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/pro.592","article-title":"Protein disulfide isomerase isomerizes non-native disulfide bonds in human proinsulin independent of its peptide-binding activity","volume":"20","author":"Winter","year":"2011","journal-title":"Protein Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200911086","article-title":"Ero1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis","volume":"188","author":"Zito","year":"2010","journal-title":"J Cell Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1420","article-title":"Endoplasmic reticulum oxidoreductin-1-Like beta (Ero1lbeta) regulates susceptibility to endoplasmic reticulum stress and is induced by insulin flux in beta-cells","volume":"152","author":"Khoo","year":"2011","journal-title":"Endocrinology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2006.8.1391","article-title":"The endoplasmic reticulum: Folding, calcium homeostasis, signaling, and redox control","volume":"8","author":"Gorlach","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1145","article-title":"Carbonylation contributes to Serca2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes","volume":"60","author":"Shao","year":"2011","journal-title":"Diabetes"},{"key":"B74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2016.04.009","article-title":"Inherent er stress in pancreatic islet beta cells causes self-recognition by autoreactive T cells in type 1 diabetes","volume":"72","author":"Marre","year":"2016","journal-title":"J Autoimmun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2020.100062","article-title":"Investigating the potential impact of post translational modification of auto-antigens by tissue transglutaminase on humoral islet autoimmunity in type 1 diabetes","volume":"8","author":"Donnelly","year":"2020","journal-title":"Metabol Open"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a135611","article-title":"Affinity chromatography of peptidylarginine deiminase from rabbit skeletal muscle on a column of soybean trypsin inhibitor (Kunitz)-sepharose","volume":"99","author":"Takahara","year":"1986","journal-title":"J Biochem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-59542-9_2","article-title":"Human deiminases: Isoforms, substrate specificities, kinetics, and detection","volume":"106","author":"Amin","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2220\/biomedres.22.63","article-title":"Peptidylarginine deiminase type I, type ii, type iii and type iv are expressed in rat epidermis","volume":"22","author":"Ishigami","year":"2001","journal-title":"Biomed Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/art.22983","article-title":"Peptidyl arginine deiminase type 2 (Pad-2) and pad-4 but not pad-1, pad-3, and pad-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation","volume":"56","author":"Foulquier","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0421","article-title":"Peptidylarginine deiminase inhibition prevents diabetes development in nod mice","volume":"70","author":"Sodre","year":"2021","journal-title":"Diabetes"},{"key":"B81","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-016-1000-7","article-title":"Reduced glutathione as a physiological Co-activator in the activation of peptidylarginine deiminase","volume":"18","author":"Damgaard","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2017.1368505","article-title":"Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase","volume":"32","author":"Damgaard","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-022-04186-5","article-title":"Ros-induced Padi2 downregulation accelerates cellular senescence Via the stimulation of sasp production and nfkappab activation","volume":"79","author":"Kim","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B84","first-page":"46","article-title":"Oxidative stress in patients with rheumatoid arthritis","volume":"67","author":"Garcia-Gonzalez","year":"2015","journal-title":"Rev Invest Clin"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-014-2006-6","article-title":"Oxidative stress in rheumatoid arthritis patients: Relationship to diseases activity","volume":"391","author":"Veselinovic","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jat.736","article-title":"The glutathione defense system in the pathogenesis of rheumatoid arthritis","volume":"21","author":"Hassan","year":"2001","journal-title":"J Appl Toxicol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00244","article-title":"Thioredoxin modulates protein arginine deiminase 4 (Pad4)-catalyzed citrullination","volume":"10","author":"Nagar","year":"2019","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5953685","article-title":"Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications","volume":"2019","author":"Bigagli","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.10.1736","article-title":"Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents","volume":"21","author":"Dominguez","year":"1998","journal-title":"Diabetes Care"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e9923","DOI":"10.1371\/journal.pone.0009923","article-title":"Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients\u2019 skin which are normalized by kidney-pancreas transplantation","volume":"5","author":"Folli","year":"2010","journal-title":"PloS One"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(96)02051-5","article-title":"Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues","volume":"20","author":"Lenzen","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1042\/bj1990393","article-title":"Cuzn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse","volume":"199","author":"Grankvist","year":"1981","journal-title":"Biochem J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196570","article-title":"Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation","volume":"13","author":"Miki","year":"2018","journal-title":"PloS One"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2012.81","article-title":"Evidence for augmented oxidative stress in the subjects with type 1 diabetes and their siblings: A possible preventive role for antioxidants","volume":"66","author":"Neyestani","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.11.005","article-title":"Antioxidant and anti-diabetic potential of passiflora alata Curtis aqueous leaves extract in type 1 diabetes mellitus (Nod-mice)","volume":"18","author":"Colomeu","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":":193\u2013205","DOI":"10.3390\/antiox10020193","article-title":"Prevention of autoimmune diabetes in nod mice by dimethyl fumarate","volume":"10","author":"Li","year":"2021","journal-title":"Antioxid (Basel)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.176","article-title":"Treatment with antioxidants at onset of type 1 diabetes in children: A randomized, double-blind placebo-controlled study","volume":"17","author":"Ludvigsson","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"B98","doi-asserted-by":"publisher","first-page":":161\u201372","DOI":"10.3390\/nu12010161","article-title":"Efficacy and safety of resveratrol in type 1 diabetes patients: A two-month preliminary exploratory trial","volume":"12","author":"Movahed","year":"2020","journal-title":"Nutrients"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3945\/an.112.003319","article-title":"Protein carbonylation, mitochondrial dysfunction, and insulin resistance","volume":"4","author":"Frohnert","year":"2013","journal-title":"Adv Nutr"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-142","article-title":"Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in huvec and hmvec","volume":"12","author":"Patel","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"304re7","DOI":"10.1126\/scitranslmed.aac4765","article-title":"Excessive caloric intake acutely causes oxidative stress, Glut4 carbonylation, and insulin resistance in healthy men","volume":"7","author":"Boden","year":"2015","journal-title":"Sci Transl Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mas.21381","article-title":"Protein carbonylation as a major hallmark of oxidative damage: Update of analytical strategies","volume":"33","author":"Fedorova","year":"2014","journal-title":"Mass Spectrom Rev"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1021\/pr500324y","article-title":"Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus","volume":"13","author":"Bollineni","year":"2014","journal-title":"J Proteome Res"},{"key":"B104","article-title":"Protein carbonylation as Biomarker(S) in serum patients with type 2 diabetes","volume":"4","author":"Gupta","year":"2011","journal-title":"J Pharm Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8227(00)00197-2","article-title":"Oxidative protein damage in early stage type 1 diabetic patients","volume":"50","author":"Telci","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0493","article-title":"Amylase alpha-2a autoantibodies: Novel marker of autoimmune pancreatitis and fulminant type 1 diabetes","volume":"58","author":"Endo","year":"2009","journal-title":"Diabetes"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.148205","article-title":"Autoimmune markers in diabetes","volume":"57","author":"Winter","year":"2011","journal-title":"Clin Chem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/art.41019","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in Mrl\/Lpr mice and experimental autoimmune encephalomyelitis","volume":"71","author":"Kono","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"Palsson-McDermott","year":"2020","journal-title":"Cell Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":":4962\u201376","DOI":"10.3390\/ijms20194962","article-title":"Pharmacological targeting of Glut1 to control autoreactive T cell responses","volume":"20","author":"Di Dedda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90051-7","article-title":"Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells","volume":"55","author":"Thorens","year":"1988","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-020-02383-4","article-title":"Glucose transporters in pancreatic islets","volume":"472","author":"Berger","year":"2020","journal-title":"Pflugers Arch"},{"key":"B113","doi-asserted-by":"publisher","first-page":":143\u201358","DOI":"10.3390\/biom12010143","article-title":"Antioxidant roles of Sglt2 inhibitors in the kidney","volume":"12","author":"Llorens-Cebria","year":"2022","journal-title":"Biomolecules"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258054","article-title":"Sglt2 inhibitors therapy protects glucotoxicity-induced beta-cell failure in a mouse model of human katp-induced diabetes through mitigation of oxidative and er stress","volume":"17","author":"Shyr","year":"2022","journal-title":"PloS One"},{"key":"B115","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3892\/etm.2021.9813","article-title":"Efficacy and safety of the Sglt2 inhibitor dapagliflozin in type 1 diabetes: A meta-analysis of randomized controlled trials","volume":"21","author":"Huang","year":"2021","journal-title":"Exp Ther Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2016.1","article-title":"Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus","volume":"23","author":"Lu","year":"2016","journal-title":"Gene Ther"},{"key":"B117","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4252\/wjsc.v13.i3.193","article-title":"Functional maturation of immature beta cells: A roadblock for stem cell therapy for type 1 diabetes","volume":"13","author":"Sun","year":"2021","journal-title":"World J Stem Cells"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1101\/gad.294389.116","article-title":"All mixed up: Defining roles for beta-cell subtypes in mature islets","volume":"31","author":"Liu","year":"2017","journal-title":"Genes Dev"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2018.11.013","article-title":"6-Phosphofructo-2-Kinase\/Fructose-2,6-Biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer","volume":"20","author":"Yi","year":"2019","journal-title":"Mol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.10.004","article-title":"Alpha-enolase: A target of antibodies in infectious and autoimmune diseases","volume":"6","author":"Terrier","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21388","article-title":"Seroreactivity against glycolytic enzymes in inflammatory bowel disease","volume":"17","author":"Vermeulen","year":"2011","journal-title":"Inflammation Bowel Dis"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00505","article-title":"Impact of autoantibodies against glycolytic enzymes on pathogenicity of autoimmune retinopathy and other autoimmune disorders","volume":"8","author":"Adamus","year":"2017","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B124","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.chembiol.2018.03.002","article-title":"The rheumatoid arthritis-associated citrullinome","volume":"25","author":"Tilvawala","year":"2018","journal-title":"Cell Chem Biol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cmet.2020.10.006","article-title":"Multi-tissue acceleration of the mitochondrial phosphoenolpyruvate cycle improves whole-body metabolic health","volume":"32","author":"Abulizi","year":"2020","journal-title":"Cell Metab"},{"key":"B126","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits Cd4(+) T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metab"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/BF00918090","article-title":"Antimitochondrial (Pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases","volume":"12","author":"Zurgil","year":"1992","journal-title":"J Clin Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.08.021","article-title":"Integrated, step-wise, mass-isotopomeric flux analysis of the tca cycle","volume":"22","author":"Alves","year":"2015","journal-title":"Cell Metab"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.2007.s389","article-title":"Stimulus\/Secretion coupling factors in glucose-stimulated insulin secretion: Insights gained from a multidisciplinary approach","author":"Newgard","year":"2002","journal-title":"Diabetes"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1319-6","article-title":"Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes","volume":"52","author":"MacDonald","year":"2009","journal-title":"Diabetologia"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C111.279927","article-title":"Action of protein disulfide isomerase on proinsulin exit from endoplasmic reticulum of pancreatic beta-cells","volume":"287","author":"Rajpal","year":"2012","journal-title":"J Biol Chem"},{"key":"B132","doi-asserted-by":"publisher","first-page":":e44528\u201349","DOI":"10.7554\/eLife.44528","article-title":"Pdia1\/P4hb is required for efficient proinsulin maturation and ss cell health in response to diet induced obesity","volume":"8","author":"Jang","year":"2019","journal-title":"Elife"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-Cd3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1912500","article-title":"Type 1 diabetes TrialNet study g. teplizumab in relatives at risk for type 1 diabetes. reply","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00248","article-title":"Prediction and prevention of type 1 diabetes","volume":"11","author":"Primavera","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B136","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12967-021-02778-6","article-title":"Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era","volume":"19","author":"Akil","year":"2021","journal-title":"J Transl Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05398-3","article-title":"Current and future therapies for type 1 diabetes","volume":"64","author":"von Scholten","year":"2021","journal-title":"Diabetologia"},{"key":"B138","doi-asserted-by":"publisher","first-page":":e142242\u201352","DOI":"10.1172\/JCI142242","article-title":"Type 1 diabetes mellitus: Much progress, many opportunities","volume":"131","author":"Powers","year":"2021","journal-title":"J Clin Invest"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.1998.tb01223.x","article-title":"Epitope spreading: The role of self peptides and autoantigen processing by b lymphocytes","volume":"164","author":"Mamula","year":"1998","journal-title":"Immunol Rev"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.32.22321","article-title":"Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins","volume":"274","author":"Mamula","year":"1999","journal-title":"J Biol Chem"},{"key":"B141","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/08916934.2012.710859","article-title":"Autoimmunity to isomerized histone H2b in systemic lupus erythematosus","volume":"46","author":"Doyle","year":"2013","journal-title":"Autoimmunity"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4541","article-title":"Intracellular protein modification associated with altered T cell functions in autoimmunity","volume":"177","author":"Yang","year":"2006","journal-title":"J Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.02.018","article-title":"Impact of carbonylation on glutathione peroxidase-1 activity in human hyperglycemic endothelial cells","volume":"16","author":"Sultan","year":"2018","journal-title":"Redox Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0955","article-title":"Preventing beta-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.11.177","article-title":"Citrullination of proteins: A common post-translational modification pathway induced by different nanoparticles in vitro and in vivo","volume":"7","author":"Mohamed","year":"2012","journal-title":"Nanomed (Lond)"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1136\/adc.59.8.739","article-title":"Increased prevalence of coeliac disease in diabetes","volume":"59","author":"Maki","year":"1984","journal-title":"Arch Dis Child"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(86)81042-3","article-title":"Celiac disease in insulin-dependent diabetes mellitus","volume":"108","author":"Savilahti","year":"1986","journal-title":"J Pediatr"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087768","article-title":"Celiac disease and insulin-dependent diabetes mellitus. screening in an adult population","volume":"39","author":"Sategna-Guidetti","year":"1994","journal-title":"Dig Dis Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0962","article-title":"Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine","volume":"58","author":"Maglio","year":"2009","journal-title":"Diabetes"},{"key":"B151","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jim.2016.01.011","article-title":"A multiplex assay combining insulin, gad, ia-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease","volume":"430","author":"Zhao","year":"2016","journal-title":"J Immunol Methods"},{"key":"B152","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A randomized trial of a transglutaminase 2 inhibitor for celiac disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N Engl J Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of Pad4 activity is sufficient to disrupt mouse and human net formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat Chem Biol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00485","article-title":"Netosis as source of autoantigens in rheumatoid arthritis","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716250","article-title":"Applicability of small-molecule inhibitors in the study of peptidyl arginine deiminase 2 (Pad2) and Pad4","volume":"12","author":"Martin Monreal","year":"2021","journal-title":"Front Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12294","article-title":"Present status of clinical deployment of glucokinase activators","volume":"6","author":"Nakamura","year":"2015","journal-title":"J Diabetes Investig"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30105-0","article-title":"Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: A dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study","volume":"6","author":"Zhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2684","article-title":"The Simplicit1 study: A randomized, double-blind, placebo-controlled phase 1b\/2 adaptive study of Ttp399, a hepatoselective glucokinase activator, for adjunctive treatment of type 1 diabetes","volume":"44","author":"Klein","year":"2021","journal-title":"Diabetes Care"},{"key":"B159","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaut.2016.03.010","article-title":"B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of igg and iga antibodies to citrullinated antigens","volume":"70","author":"Cambridge","year":"2016","journal-title":"J Autoimmun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, b-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0626","article-title":"B-lymphocyte depletion with rituximab and beta-cell function: Two-year results","volume":"37","author":"Pescovitz","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1028130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T05:59:02Z","timestamp":1666850342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1028130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":161,"alternative-id":["10.3389\/fimmu.2022.1028130"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1028130","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"article-number":"1028130"}}